Related scientific articles (all)

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance.

Authors : Van Damme M, Crompot E, Meuleman N, Maerevoet M, Mineur P, Bron D, Lagneaux L, Stamatopoulos B
Year : 2016
Journal : Clin Epigenetics
Volume : 8
Pages : 132

In Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction.

Authors : Aoun F, Albisinni S, Chemaly AK, Zanaty M, Roumeguere T
Year : 2016
Journal : Asian Pac J Cancer Prev
Volume : 17
Pages : 1-13

Are virus-induced cancers more sensitive to checkpoint inhibitors?

Authors : Kanaan H, Kourie HR, Awada A
Year : 2016
Journal : Future Oncol
Volume : 12(23)
Pages : 2665-68

Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patients.

Authors : Maiter D, Bex M, Vroonen L, TSjoen G, Gil T, Banh C, Chadarevian R
Year : 2016
Journal : Ann Endocrinol (Paris)
Volume : 77(5)
Pages : 578-85

Adjuvant endocrine therapy in preand perimenopausal women with breast cancer: practice guidelines

Authors : Duhoux F, Neven P, Awada A, Berlière M, Wildiers H, Denys H
Year : 2016
Journal : Belgian J Medical Oncology
Volume : 10(3)
Pages : 92-96

Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.

Authors : Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EG, Piccart-Gebhart M
Year : 2016
Journal : Ann Oncol
Volume : 27
Pages : 203-5

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.

Authors : Maertens JA, Raad II, Marr KA, Patterson TF, Kontoyiannis DP, Cornely OA, Bow EJ, Rahav G, Neofytos D, Aoun M, Baddley JW, Giladi M, Heinz WJ, Herbrecht R, Hope W, Karthaus M, Lee DG, Lortholary O, Morrison VA, Oren I, Selleslag D, Shoham S, Thompson GR 3rd, Lee M, Maher RM, Schmitt-Hoffmann AH, Zeiher B, Ullmann AJ
Year : 2016
Journal : Lancet
Volume : 387(10020)
Pages : 760-9

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines.

Authors : Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, Herrstedt J
Year : 2016
Journal : Ann Oncol
Volume : 27
Pages : v111-v118

No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.

Authors : Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y
Year : 2016
Journal : J Clin Oncol
Volume : 34(22)
Pages : 2568-74

Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program.

Authors : Van Praet C, Rottey S, Van Hende F, Pelgrims G, Demey W, Van Aelst F, Wynendaele W, Gil T, Schatteman P, Filleul B, Schallier D, Machiels JP, Schrijvers D, Everaert E, Dhont L, Werbrouck P, Vermeij J, Mebis J, Clausse M, Rasschaert M, Van Erps J, Verheezen J, Van Haverbeke J, Goeminne JC, Lumen N
Year : 2016
Journal : Urol Oncol
Volume : 34(6)
Pages : 254.e7-254.e13

Approach and complications associated with suburethral synthetic slings in women: Systematic review and meta-analysis.

Authors : Biardeau X, Zanaty M, Aoun F, Benbouzid S, Peyronnet B
Year : 2016
Journal : Prog Urol
Volume : 26(4)
Pages : 254-69

Continuous Renal Replacement Therapy for Acute Renal Failure in Patients with Cancer: A Well-Tolerated Adjunct Treatment.

Authors : Fischler R, Meert AP, Sculier JP, Berghmans T
Year : 2016
Journal : Front Med (Lausanne)
Volume : 3
Pages : 33

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.

Authors : Woff E, Hendlisz A, Garcia C, Deleporte A, Delaunoit T, Maréchal R, Holbrechts S, Van den Eynde M, Demolin G, Vierasu I, Lhommel R, Gauthier N, Guiot T, Ameye L, Flamen P
Year : 2016
Journal : Eur J Nucl Med Mol Imaging
Volume : 43(10)
Pages : 1792-801

Dose-Seeking Phase I Trials for Currently Approved Molecular-Targeted Therapies in the USA: The Dose-Limiting Toxicity Definition Issue

Authors : Kotecki N, Awada A, Bonneterre J, Hebbar M, Adenis A, Cortot AB, Cousin C, Clisant S, Duhamel A, Penel N
Year : 2016
Journal : Pharmaceutical Medicine
Volume : 30(3)
Pages : 143-7

Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study.

Authors : Tolaney SM, Nechushtan H, Ron IG, Schöffski P, Awada A, Yasenchak CA, Laird AD, OKeeffe B, Shapiro GI, Winer EP
Year : 2016
Journal : Breast Cancer Res Treat
Volume : 160
Pages : 305-312

Predictors of physicians' satisfaction with their management of uncertainty during a decision-making encounter with a simulated advanced stage cancer patient.

Authors : Libert Y, Canivet D, Ménard C, Van Achte L, Farvacques C, Merckaert I, Liénard A, Klastersky J, Reynaert C, Slachmuylder JL, Durieux JF, Delvaux N, Razavi D
Year : 2016
Journal : Patient Educ Couns
Volume : 99(7)
Pages : 1121-9

Lower urinary tract dysfunction following nerve sparing radical hysterectomy: A systematic review.

Authors : Aoun F, Albisinni S, Peltier A, Maoula A, Van Velthoven R, Roumeguère T
Year : 2016
Journal : Prog Urol
Volume : 26(1)
Pages : 1-9

Sentinel Lymph Node Detection by Blue Dye Versus Indocyanine Green Fluorescence Imaging in Colon Cancer.

Authors : Liberale G, Vankerckhove S, Gomez Galdon M, Larsimont D, Ahmed B, Bouazza F, Moreau M, El Nakadi I, Donckier V, Bourgeois P
Year : 2016
Journal : Anticancer Res
Volume : 36
Pages : 4853-8

Will Testicular Germ Cell Tumors Remain Untargetable?

Authors : Aoun F, Kourie HR, Albisinni S, Roumeguère T
Year : 2016
Journal : Target Oncol
Volume : 11(6)
Pages : 711-21

Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer.

Authors : Hamm A, Prenen H, Van Delm W, Di Matteo M, Wenes M, Delamarre E, Schmidt T, Weitz J, Sarmiento R, Dezi A, Gasparini G, Rothé F, Schmitz R, Dhoore A, Iserentant H, Hendlisz A, Mazzone M
Year : 2016
Journal : Gut
Volume : 65(6)
Pages : 990-1000